Back
RxSight 10K Form
Sell
30
RXST
RxSight
Last Price:
53.42
Seasonality Move:
-0.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RXST News And Ratings
See the #1 stock for the next 7 days that we like better than RXST
RXST Financial Statistics
Sales & Book Value
| Annual Sales: | $89.08M |
|---|---|
| Cash Flow: | $-5.55M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.95 |
| Price / Book: | 7.81 |
Profitability
| EPS (TTM): | -1.01000 |
|---|---|
| Net Income (TTM): | $-36.77M |
| Gross Margin: | $53.77M |
| Return on Equity: | -20.02% |
| Return on Assets: | -17.54% |
RxSight Earnings Forecast
Key RxSight Financial Ratios
- The Gross Profit Margin over the past 5 years for RXST is 60.36%.
- The Selling, General & Administrative Expenses for RXST have been equal to 83.97% of Gross Profit Margin.
- The Research & Development expenses have been 32.61% of Revenue.
- The Interest Expense is -6.81% of Operating Income.
- The Net Earning history of RXST is -54.57% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 2 years.
RxSight Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | RXST |
| Website: | rxsight.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 14.33 |
| Quick Ratio: | 13.2 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 297.58 |